Posted by Michael Wonder on 02 Jun 2023
Foslevodopa-foscarbidopa for treating Parkinson’s disease with motor symptoms
31 May 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of foslevodopa–foscarbidopa in the NHS in England.
Foslevodopa–foscarbidopa is not recommended for the treatment of adults with advanced levodopa-responsive Parkinson’s disease whose symptoms include severe motor fluctuations and hyperkinesia or dyskinesia, when available treatments are not working well enough.
